Catecholamines in cardiac hypertrophy
- 1 June 1999
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 83 (12) , 70-74
- https://doi.org/10.1016/s0002-9149(99)00264-7
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- The MEKK-JNK Pathway Is Stimulated by α1-Adrenergic Receptor and Ras Activation and Is Associated with in Vitro and in Vivo Cardiac HypertrophyJournal of Biological Chemistry, 1997
- BASIC DETERMINANTS OF MYOCARDIAL HYPERTROPHY: A Review of Molecular MechanismsAnnual Review of Medicine, 1997
- Circulating Levels of Cytokines and Their Endogenous Modulators in Patients With Mild to Severe Congestive Heart Failure Due to Coronary Artery Disease or HypertensionJournal of the American College of Cardiology, 1996
- The Mitogen-activated Protein Kinase Kinase MEK1 Stimulates a Pattern of Gene Expression Typical of the Hypertrophic Phenotype in Rat Ventricular CardiomyocytesPublished by Elsevier ,1995
- Pheochromocytoma with catecholamine-induced impairment of cardiac neuronal functionAmerican Heart Journal, 1995
- Cellular mechanisms of cardiac hypertrophy.Heart, 1995
- Enhanced Myocardial Function in Transgenic Mice Overexpressing the β 2 -Adrenergic ReceptorScience, 1994
- Modulation of cardiac myocyte beating rate and hypertrophy by cardiac fibroblasts isolated from neonatal rat ventricle.Japanese Circulation Journal, 1993
- Absence of hypertension despite chronic marked elevations in plasma norepinephrine in conscious dogs.Hypertension, 1987
- Hemodynamic versus adrenergic control of cat right ventricular hypertrophy.Journal of Clinical Investigation, 1985